SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-037695
Filing Date
2024-02-16
Accepted
2024-02-15 18:23:32
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d42232ds3.htm S-3 228826
2 EX-5.1 d42232dex51.htm EX-5.1 8607
3 EX-23.1 d42232dex231.htm EX-23.1 1674
4 EX-FILING FEES d42232dexfilingfees.htm EX-FILING FEES 16177
5 GRAPHIC g42232g15m02.jpg GRAPHIC 668741
6 GRAPHIC g42232g42w05.jpg GRAPHIC 73256
7 GRAPHIC g42232g59r04.jpg GRAPHIC 9817
8 GRAPHIC g42232g80d44.jpg GRAPHIC 5477
  Complete submission text file 0001193125-24-037695.txt   1290724
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277123 | Film No.: 24645233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)